Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-040698
Filing Date
2004-03-12
Accepted
2004-03-12 17:18:42
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMEBER 31, 2003 d10k.htm 10-K 968326
3 CERTIFICATE OF DESIGNATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK dex35.htm EX-3.5 6535
4 AMENDMENT dex45.htm EX-4.5 11892
5 FIFTH AMENDMENT OF LEASE dex1063.htm EX-10.63 10778
6 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 2757
7 CERTIFICATE OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 8107
8 CERTIFICATE OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 8032
9 CERTIFICATE OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3002
10 CERTIFICATE OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2886
  Complete submission text file 0001193125-04-040698.txt   1024943
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21643 | Film No.: 04666978
SIC: 2836 Biological Products, (No Diagnostic Substances)